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Alzheimer's disease (AD) and heart failure (HF) are two complex diseases that are caused by 
the combination of genetic and epigenetic, environmental and other lifestyle factors. 
Understanding the relationships between genetic and epigenetic variants and other factors of 
such complex diseases could assist researchers discover disease mechanisms and develop 
targeted therapies.  
 
Much of the research in genetics/epigenetics studies regarding AD and heart diseases have 
been focused on association analysis. Many researchers have identified genetic/epigenetics 
variants and phenotypes that are significantly associated with disease pathology. While most 
of these studies utilize association analysis as the analytical platform, the signals identified by 
association studies can only explain a small proportion of the heritability of complex diseases 
and a large proportion of risk factors remain undiscovered, which is the limitation of genome-
 
 
wide association studies (GWAS). In addition, the biological system usually functions in a 
systematic or causal way, thus causation analysis is key to uncover the risk mechanisms of 
complex diseases. The relationship between association and causation is that causation can be 
used to infer association, but the reverse cannot be guaranteed. Traditionally, the gold standard 
for causation analysis is using interventions in randomized controlled trials (RCT). However, 
RCT is not feasible for genetics/epigenetics data for either ethical or technical reasons.  
 
The major objective of this research is thus to propose methods to uncover the causal 
mechanisms between genetic/epigenetic factors and phenotypes such as environmental and 
lifestyle factors for complex diseases. First, I proposed a bivariate causal discovery method to 
uncover the pairwise causal relationships between factors. Second, I proposed a network 
analysis framework to construct the causal network among genetic/epigenetic variants and 
phenotypic factors. Finally, I applied the bivariate causal discovery method and causal network 
construction method to the two complex diseases: Alzheimer's disease (AD) and heart failure 
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1.1 Literature Review 
1.1.1 Alzheimer’s Disease 
 
Alzheimer's disease (AD) is an irreversible chronic neurodegenerative disease that causes 
problems with memory, thinking, behavior and social skills, and is not a normal part of aging 
(Burns and Iliffe 2009). It has been estimated that the number of people with Alzheimer’s 
disease will be up to 13.8 million in the United States by the year of 2050 (Alzheimer's & 
Dementia 2017). The disease is named after Dr. Alois Alzheimer who noticed changes in the 
brain tissue of a woman who had died of an unusual mental illness with symptoms of memory 
loss, language problems, and unpredictable behavior in 1906 (Berchtold and Cotman 1998).  
 
AD contributes to 60 to 80 percent of dementia that leads to continuous loss of memory and 
other cognitive abilities and worsens over time, which would disrupt a person's ability to 
function independently. Experts suggest that more than 5.5 million Americans may have 
Alzheimer’s caused dementia with the majority of them being age 65 or older (NIH 2020). 
Most commonly, people with Alzheimer’s symptoms first appear in their mid-60s. The early 
signs may include forgetting newly learned information, but as disease progresses, there will 
be onset of severe memory and cognitive impairment. Typical symptoms may include 
disorientation, mood and behavior changes; serious confusions about events, time and place 
and suspicions about family and friends; more worsening memory loss and behavior changes. 
Patients may also experience difficulty in speaking, swallowing and walking. Ultimately, 
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patients will lose the ability to carry out the simplest daily and cognitive tasks, and even have 
to depend completely on others to perform basic activities of daily living (Alzheimer’s 
Association 2020). Unfortunately, current treatments for AD symptoms are not able to prevent 
or hamper the progression of the disease and no current cure is available.  
 
Many researchers have been studying Alzheimer’s disease and discovered that brain proteins 
of AD patients fail to function normally. Researchers also identified several candidate genes 
that may be related to the onset of AD. For example, having one form of the apolipoprotein E 
(APOE) gene does increase a person’s risk of getting AD (Strittmatter et al. 2019; Mahley and 
Huang 2006; Hall et al. 2006). However, the exact cause of the brain proteins damage and 
disease has not been fully understood. The cause for most Alzheimer's cases is still mostly 
unknown except for 1% to 5% of cases where genetic factors have been identified (Reitz and 
Mayeux 2014). Scientists believe that AD is caused by a combination of genetic, 
environmental, and lifestyle factors, which is yet to be confirmed.  As a result, in this 
dissertation, we developed a causal analysis framework to assess the causal relationship 
between various types of factors (such as genetic/epigenetic and phenotypic factors) on 
Alzheimer’s disease patients, to help understand the mechanism of AD. 
 
 




Heart failure (HF), also known as congestive heart failure, is a chronic and progressive disease 
that the heart muscle is not pumping properly. It usually leads to providing insufficient blood 
to meet body’s needs and not enough force to pump blood to the rest of the body, thus the body 
gets less oxygen than it needs (Mayo Clinic 2020). Today, about 5.8 million people in the 
United States have heart failure, affecting both children and adults, and heart failure is 
considered a common condition. Overall, there are around 2% of adults affected by heart 
failure and the percentage increases to 6–10% in those over the age of 65. And for those above 
75 years old, the rates are greater than 10% (Dickstein et al. 2008; Metra and Teerlink 2017). 
 
Heart failure can be ongoing or occur suddenly. The common signs and symptoms may include 
shortness of breath (could be accompanied by coughing), fatigue and weakness of your body 
(tiredness), swelling in some of your body (i.e. ankles, feet, legs, abdomen, and veins in the 
neck), increased need to urinate at night, etc. If the heart failure is caused by heart attack, there 
will also be presence of chest pain. As disease progresses, it is difficult to perform everyday 
activities such as walking, climbing stairs, dressing clothes or carrying groceries (National 
Clinical Guideline Centre (UK) 2010).   
 
Heart failure is considered as a complex disease which is a result of multifactorial interaction 
among genetic predisposition, environmental and lifestyle factors. Common risk factors 
include high blood pressure, diabetes, other heart diseases or conditions, tobacco and alcohol 
use. HF condition can be further complicated if other diseases co-exist, such as kidney and 
liver failure. Genetic predisposition is also a risk factor such as family histories of heart failure 
4 
 
(American Heart Association 2020). Unfortunately, similar to Alzheimer’s disease, there is no 
current cure to heart failure. Current treatments can improve the signs and symptoms of heart 
failure and thus improve the quality of life and the lifespan of patients. Treatments may include 
keeping a healthy lifestyle, taking medications and medical procedures and surgeries. 
 
Researchers have also tried to understand the mechanism of heart failure through scientific 
research. Exploring the interactions among different types of traits among heart failure patients 
could deepen our understanding of disease mechanism and help develop targeted therapies. 
However, in genetic and epigenetic studies, most research have focused on association analysis. 
Although some risk factors have been identified to be associated with the disease, there is a 
need to uncover the causal relationships among multiple risk factors. Through causation studies, 
we can further explore the mechanism of heart failure and provide instructions for clinical 
treatments. For example, there has been increasing research recently assessing the influence of 
genetic variations on metabolism and other risk factors of heart failure. The dicarboxylic acid 
hexadecanedioate (hexadecanedioate) is a metabolite that has been identified to be associated 
with blood pressure (Alharbi et al, 2017). Many GWAS studies have discovered several genetic 
loci associated with hexadecanedioate, but currently there is limited research focusing on the 
causal interactions among genes, hexadecanedioate and blood pressure. This dissertation 






1.1.3 Bivariate Causal Discovery 
 
Genome-wide association analysis (GWAS) has been widely used to test the pairwise 
association between genetic variants and phenotypes, dealing with different data types. For 
example, the relationship between a discrete variable and a continuous variable; the 
relationship between two continuous variables; the relationship between two discrete 
variables. But there is no current method uncovering the causal relationships between two 
observed variables for human genetics data when randomized controlled experiments are not 
feasible. Causation analysis in statistics, refers to the establishment of cause and effect 
(Rohlfing and Schneider 2018), or in other words, regards the problem of drawing 
conclusions about whether some entity we can observe influences another entity (Kurthen 
and Enßlin 2020). In probability setting, suppose that 𝑋 and 𝑌 are two random variables with 
joint distribution 𝑃(𝑋, 𝑌). If an external intervention that is from outside the system under 
consideration forces the variable 𝑋 to have the value 𝑥 and keeps the rest of the system 
unchanged, after 𝑌 is measured, the resulting distribution of 𝑌, 𝑃(𝑌|𝑑𝑜(𝑥) is defined as the 
causal effect of 𝑋 on 𝑌 (Pearl 2012). 
 
As mentioned, GWAS analysis lacks the ability to detect causal relationships between two 
variables. To transit from association to causation analysis, researchers proposed several 
bivariate causal discovery methods to evaluate the causal relationships between two observed 
variables. Additive Noise Model (ANM) (Hoyer et al., 2009), information geometry causality 
inference (Daniusis et al., 2010; Janzing et al., 2012) and linear non-Gaussian acyclic model 
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(Shimizu et al., 2006) are methods discussed in past literature and assume different 
assumptions. In this dissertation, the additive noise models (ANM) was utilized for bivariate 
causal discovery (Hoyer et al. 2009) focusing on two continuous variables.  
 
For ANM, there are three major assumptions: 1. no selection bias, 2. no feedback and no 
confounding, 3. independence of cause and mechanism (ICM) (Mooij. 2016). ICM means 
that the mechanism that generates cause 𝑋 and the mechanism that generates effect 𝑌 from the 
cause 𝑋  are independent. In probability setting, this could be expressed as the cause 
distribution 𝑃(𝑋) and the conditional distribution 𝑃(𝑌|𝑋)  being independent. 
 
The expression of ANM is the following (Mooij. 2016): 
𝑌 = 𝑓(𝑋) + 𝑒 
 
In the equation, 𝑌 is a non-linear function of potential cause 𝑋 plus a random error 𝑒, which 
can be with any distributions. Alternatively, we could assess potential cause 𝑌 on effect 𝑋: 
𝑋 = 𝑓(𝑌) + 𝑒 
 
It is worth noting that only one of the two causal directions could hold for ANM: 𝑋 → 𝑌 or 𝑌 →
𝑋. That is, at most one of the two directions could hold. 
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Under ICM assumption, the principal for inferring causal direction under ANM is then 
transformed into testing the independence between the cause and the residual term. The method 




1.1.4 Hilbert-Schmidt Independence Criterion 
 
There is a wide range of dependence measures for statistical test of independence, for example, 
Pearson and Spearman correlation test. Covariance can be used to measure association between 
two variables, but it lacks the ability to test the independence between two variables for all 
settings. For example, it does not work when the two variables are not jointly normally 
distributed. As a result, kernel-based independence measures have been developed to evaluate 
dependencies between variables. Hilbert-Schmidt independence criterion (HSIC) was thus 
proposed by researchers to measure the degree of dependence between two variables (Gretton 
et al. 2005).  
 
Calculation of the HSIC consists of the following steps (Mooij et al. 2016). 
Step 1: Use test dataset to fit the regression model. 
𝑦𝑖 = 𝑓(𝑥𝑖) + 𝐸𝑌(𝑖), 𝑖 = 1, … , 𝑚. (𝑚 observations) 
Step 2: Calculate the residuals from the model obtained above: 
𝜀𝑖 = 𝐸𝑌(𝑖) = 𝑦𝑖 − 𝑓(𝑥𝑖), = 1, … , 𝑚. 
8 
 
Step 3: Select two Gaussian kernel functions ),( jiEk  and ),( 21 xxkx  (Gretton et al. 2005). 
Calculate the Kernel matrices: 
 
𝐾𝐸𝑌 = [
𝑘𝐸(𝜀1, 𝜀1) ⋯ 𝑘𝐸(𝜀1, 𝜀𝑚)
⋮ ⋮ ⋮
𝑘𝐸(𝜀𝑚, 𝜀1) ⋯ 𝑘𝐸(𝜀𝑚, 𝜀𝑚)
], 𝐾𝑥 = [
𝑘𝑥(𝑥1, 𝑥1) ⋯ 𝑘𝑥(𝑥1, 𝑥𝑚)
⋮ ⋮ ⋮
𝑘𝑥(𝑥𝑚, 𝑥1) ⋯ 𝑘𝑥(𝑥𝑚, 𝑥𝑚)
]. 
 
Step 4: Calculate HSIC for measuring dependence between residual 𝜀𝑖 and potential cause 









𝑇 , 𝟏𝑚 = [1,1, … ,1]
𝑇 and 𝑇𝑟 denotes the trace of the matrix. 
 
 
1.1.5 Directed Acyclic Graph and Structural Equation Model 
 
Bivariate causal discovery methods such as additive noise models discussed above can be 
used to discover the causal relationship between two observed variables, but it lacks the 
ability to include additional variables into the analysis. In addition, many past genetic 
analysis of quantitative traits have focused on single trait analysis. However, the biological 
system is rather complex and multiple traits tend to be correlated. For example, multiple 
phenotypes can be correlated and bivariate discovery lacks the ability to leverage the 
correlations among different traits. To overcome the limitations of bivariate causal discovery, 
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directed graphical models and structural equation model can be utilized to model the 
complex causal structures among phenotypes, genetic and other risk factors. 
 
Directed Acyclic Graph 
 
Directed graphical model is comprised of nodes and edges. The nodes represent the variables 
while edges indicate the dependence structures among variables (nodes), and the inter-node 
connections have a direction denoted by an arrowhead. Directed acyclic graphs (DAG) 
belong to graphical models and are defined as finite directed graphs with no cycle. That is, 
it is impossible to start at a node A, travel through edges in the directions of the arrows, and 
get back to node A. Variables are represented as nodes in DAGs, with edges between nodes 
represented as causal relationships (Xiong 2018). And causal relationship between two 
variables in DAGs must be unidirectional, that is, they cannot cause each other. Figure 1 
below is an example of DAG.  
Figure 1:  A DAG Example 












Structural Equation Model 
 
In traditional regression models, the variables on the left side of the equations are dependent 
variables, while variables on the right side of the equations are independent (explanatory) 
variables. However, sometimes it is difficult to distinguish the two as the dependent 
variables in some equations can be independent variables in other equations and the 
variables in the equations may affect each other. To accommodate such settings and the 
interactions among variables, structural equation model can thus be a powerful tool to 
describe such data structure, and infer causal relationships among the variables in the 
equations. Structural equation models (SEMs) incorporate causal assumptions as part of the 
model and each equation is a representation of causal relationships between a set of variables 
(Pearl 2012). 
 
SEMs classify variables into two types: endogenous variables (X) and exogenous variables 
(Y). Endogenous variables are variables determined through joint interaction with all the 
other variables in the system or out of the system (dependent variables). Exogenous 
variables are external variables but affect the value of the endogenous variables (explanatory 
variables). In a typical SEM, the system consists of 𝑀  endogenous variables and 𝐾 
exogenous variables (𝑚 observations): 
M endogenous variables: 𝑌 = [𝑦1, . . . , 𝑦𝑀] 
𝐾 exogenous variables: X = [𝑥1, . . . , 𝑥𝑘] 
11 
 
Figure 2 below is a graphical representation of SEM, with exogenous variables being the 
cause and endogenous variables being the effect.  
 





The SEMs can be expressed in mathematical format (Xiong 2018): 
𝑦1𝛾1𝑖 + ⋯ + 𝑦𝑀𝛾𝑀𝑖 + 𝑥1𝛽1𝑖 + ⋯ + 𝑥𝐾𝛽𝐾𝑖 + 𝑒𝑖 = 0, 𝑖 = 1, ⋯ , 𝑚 
 
In matrix notation: 
𝑌Γ + 𝑋Β + 𝐸 = 0 
 
The 𝛾’s (Γ in matrix notation) and 𝛽’s (Β in matrix notation) are the unknown parameters or 
coefficients of the equation system, and E = [𝑒1, . . . , 𝑒𝑚]  denotes the random error. 𝛾 ’s 
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indicates the causal directions among endogenous variables while 𝛽’s indicates the causal 
directions from 𝑋 to 𝑌. The endogenous variables and exogenous variables are observed 
variables, where random error represent all the unmeasured factors and all other unmodeled 
causes of the variables. There are several methods of estimating the unknown parameters of 
the equations. For example, maximum likelihood method, two-state least squares (2SLS) 
method, and three-stage least squares (3SLS) method. Maximum likelihood estimation 
method assumes the normal distribution of the endogenous variables (Judge et al. 1980); 
however, it is usually unlikely in real world data that such assumption will hold. In addition, 
ordinary least square methods for parameter estimations will lead to inconsistent estimators.  
2SLS and 3SLS, on the other hand, do not assume distribution of the endogenous and 
exogenous variables (Judge et al. 1980; Zellner and Theil 1962). 2SLS is a widely used 
single equation method (Judge et al. 1980) while 3SLS fully explores information in the 
structural equations and jointly estimate all structural equations (Zellner and Theil 1962). In 
this dissertation, 2SLS as a most widely used method was utilized for SEM parameter 
estimations. 
 
1.2 Public Health Significance 
 
Alzheimer’s disease and heart failure are two complex diseases affecting millions of people 
across the globe. The diseases are caused by the combination of genetic, epigenetic, 
environmental and other lifestyle factors, however, the interplay among these factors still 
remains a challenge to researchers (Dempfle et al., 2008). Much of the research in 
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genetics/epigenetics studies regarding AD and heart diseases have been focused on association 
or correlation analysis. Genetic variants and quantitative traits have been identified to be 
significantly associated with disease pathology. Yet, the genetic variants identified from 
association studies can only explain a small proportion of the heritability of complex diseases 
and a large proportion of risk factors remain undiscovered.  In addition, the biological system 
usually functions under causal structures, thus association analysis is insufficient to dissect the 
risk mechanism of complex diseases. To explore causal inference, randomized controlled trials 
(RCT) has been widely accepted as the best framework to uncover the causal relationship 
between intervention and effect. However, randomized controlled experiments are sometimes 
expensive, unethical and technically infeasible in the field of genetics, especially for human 
genetics data. As a result, establishing causal analysis framework will enrich the investigating 
tools of understanding complex diseases pathology and facilitating public health research. 
 
The methods proposed in this dissertation provided a modeling framework to discover the 
causal relationships between risk factors and disease phenotypes. Both bivariate causal 
discovery method and network causal analysis method were discussed, with applications to 
two complex diseases: Alzheimer’s disease and heart failure. 
 
1.3 Specific Aims  
 
As discussed above, causal study is still not widely explored for Alzheimer’s disease and heart 
failure, and most genetic and epigenetic studies were based on association analysis. In addition, 
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randomized controlled trials are not viable in many observational studies to make causal 
inferences. To bridge the gap of causation analysis in the two complex diseases mentioned 
above, the major objective of this research was to propose methods to uncover the causal 
mechanism for the two diseases. This dissertation proposed methods for both pairwise causal 
discovery on continuous variables and network-based causal structure analysis. 
 
Aim 1: To develop bivariate causal discovery method for continuous variables. Additive 
noise model was proposed to deal with two continuous variables.  
 
ANM discussed in literature review can be used to deal with causation analysis between two 
observed variables. However, with only ANM, there are limitations. There is no closed 
analytical forms for the asymptotic null distribution of the HSIC, which makes it difficult to 
calculate the p-values of the independence tests between the cause and the residual term. To 
overcome the limitations, we proposed adding a permutation test to calculate the p-values 
of the causal test statistics. 
 
Aim 2: To develop the causal network-based model to account for more variables into the 
analysis. A structural equations model with integer programming (IP) was proposed (SEM 
with IP).  
 
Under SEM and DAG, we could have a causal framework to construct the causal network 
among variables. However, with pure SEM, there are limitations. SEM could potentially 
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generate a bidirectional relationship between variables, instead of unidirectional, thus 
generating cyclic graphs, instead of an acyclic graph. To overcome the limitations, we 
proposed adding an extra integer programming step to SEM model.  
 
Aim 3: To apply the ANM and SEM with IP to Alzheimer’s disease data and heart failure 
data, with the goal of uncovering the causal mechanisms in terms of genetic and phenotype 




2.1 Methods for Aim 1 
 
Aim 1: To develop bivariate causal discovery method for continuous variables. Additive 
noise model was proposed to deal with two continuous variables. 
 
2.1.1 Statistical Modeling for Additive Noise Model 
 
ANM was utilized as the method to assess bivariate causal relationships between two observed 
variables. As discussed in previous sections, ANM adopted the assumptions of no 
confounding, no selection bias and no feedback between variables. Consider a bivariate ANM 
where 𝑌 (effect) is a nonlinear function of  𝑋 (cause) and independent additive noise 𝐸𝑌: 
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              (1) 
where 𝑋 and 𝐸𝑌 are independent. Then, the density 𝑃𝑋,𝑌 is said to be inferred by the additive 
noise model from 𝑋 to 𝑌 (Mooij et al. 2016).  The alternative ANM between 𝑋 and 𝑌 is  𝑌 →
𝑋: 







                  (2) 
where 𝑌 and 𝐸𝑋 are independent. 
 
As discussed in previous sections of independence of cause and mechanism, given two random 
variables, 𝑋  and 𝑌  which are related causally, 𝑋 → 𝑌  (“  𝑋  causes 𝑌”), then there exists a 
fundamental independence between the distribution of the cause 𝑃(𝑋) and the mechanism 
which relates the cause 𝑋 to the effect 𝑌 . As a result, causation between two variables is 
defined as the independence between the distribution of cause and conditional distribution of 
the effect, given cause. In ANM, such idea of causal relationship identification is then 
transformed into testing the independence between the cause 𝑋  and the residual term 𝐸𝑌 . 
However, if there is causal relationship exist between 𝑋  and 𝑌 , only one of the causal 
directions could hold. That is, it is either 𝑋 → 𝑌 or 𝑌 → 𝑋, it cannot simultaneously exist, or 
the causation is not identified by ANM.  
 
The general procedure for bivariate causal discovery is given as follows (Mooij et al. 2016; 
Jiao et al. 2018): 
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{ mmtest XYD = . 
Step 2: Use 𝐷𝑡𝑟𝑎𝑖𝑛 and implement nonlinear regression methods for both directions (fitting the 
models). 
(a) Regress Y on X : Y = fY (X)+EY  and 
(b) Regress X on Y : X = fX (X)+EX . 








~ˆ YfXE XXY −=  
Step 4: Calculate the dependence measures ),(
2 XEHSIC Y  and ),(
2 YEHSIC X . 
Step 5: Infer causal direction based on independence tests:  
 YX →  if ),(),(
22 YEHSICXEHSIC XY  ;     (4) 
 XY →  if ),(),(
22 YEHSICXEHSIC XY  .     (5) 
 If ),(),(
22 YEHSICXEHSIC XY = , then causal direction is undecided by ANM.  
 
Larger 𝐻𝑆𝐼𝐶2 indicates stronger dependence between the cause and the residual term, which 
is evidence against causal relationships between the potential cause and effect being tested. 
 
However, with the above ANM procedure only, there are limitations when assessing causal 
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relationships in practice because there is no closed analytical form for the asymptotic null 
distribution of the HSIC. This makes it difficult to calculate the p-values of the independence 
tests between the cause and the residual term. To overcome the limitations, we proposed adding 
a permutation test to calculate the p-values of the causal test statistics. We defined a causal test 
hypothesis and a test statistic:  
 
𝐻0: no causations 𝑋 → 𝑌 and 𝑌 → 𝑋 (That is, there is no causal relationship exists between the 
two variables).       
Define a test statistic: 
                      𝑇𝐶 = |𝐻𝑆𝐼𝐶
2(𝐸𝑌, 𝑋) − 𝐻𝑆𝐼𝐶
2(𝐸𝑋 , 𝑌)|.                   (6) 
 
The permutation test was performed in the following way. Let’s suppose that the total number 
of permutations is 𝑁. For each permutation, 𝑥𝑖 , 𝑖 = 1, … , 𝑚 were fixed and 𝑦𝑖, 𝑖 = 1, … , 𝑚 
were randomly shuffled. Each permutation created a different arrangement of the observed 
data points. Then, ANM was fitted to obtain residuals 𝐸𝑋(𝑖), 𝐸𝑌(𝑖), 𝑖 = 1, … , 𝑚  and test 
statistic 𝑇𝐶  for each permutation and permutation was repeated for 𝑁  times. The goal of 
permutation test was to obtain all possible values of the test statistic under all possible 
rearrangements of the observed data points. The p-values were defined as the proportions of 
the statistic ?̃?𝐶 (calculated from the permuted data) greater than or equal to ?̂?𝐶 (calculated from 
the original data). If there is causal relationship identified by the p-values from permutation 
test, then we go to equations (4) and (5) above to infer causal directions. As mentioned 
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previously, only one of these two directions could hold. The causal relationship between two 
observed variables can then be identified by ANM. 
 
 
2.1.2 Simulation Settings for Additive Noise Model 
 
The simulation for ANM with permutation test was based on the following way. The data with 
100,000 subjects were simulated from the model:  
𝑌 = 𝑋2 + 𝑒 
where 𝑋~𝑁(0,1) and 𝑒~𝑁(0,0.01). 
 
Then the samples were randomly selected with the size of 500, 1000 and 2000 from the 
population to calculate and compare the Type I error rates and powers of the ANM causal tests. 
The number of permutations was set to 500 and the significance level was set to 0.05. 
 
2.2 Methods for Aim 2 
 
Aim 2: To develop the causal network-based model to account for more variables into the 
analysis. A structural equation model with integer programming was proposed.  
 




SEMs introduced in previous section 1.1.5 can be utilized as a causal uncovering method to 
assess the causal relationships among multiple traits. However, with pure SEM, there are 
limitations. SEM could potentially generate a bidirectional relationship between variables, 
instead of unidirectional, thus generating cyclic graphs, instead of an acyclic graph. To 
overcome the limitations, we proposed adding an extra integer programming step to SEMs. 
 
Integer programming is an optimization problem in which some or all of the variables are 
restricted to be integers. In network analysis, multiple nodes are regarded as variables, so a 
combination of SEM and optimization problem on multiple variables can be introduced to 
causal network analysis. We set 𝑣 as a node, and 𝑊 as the potential parent node, we can 
define an indicator variable 𝑥(𝑊 → 𝑣) to be either 0 or 1, to represent the presence and 
absence of parent 𝑊, indicating whether a variable should be included as cause. Thus, the 
causal directions among variables in SEMs can be restricted to unidirectional. A standard 
form of integer linear programming (Xiong 2018) is 
 
min  𝑐𝑇𝑋 
Subject to 𝐴𝑋 ≤ 𝑏 and 𝑋 ∈ 𝑍𝑛 
where 𝑐 ∈ 𝑅𝑛, 𝑏 ∈ 𝑅𝑚, 𝐴 ∈ 𝑅𝑚×𝑛 and 𝑍 = {0,1,2, … } 
 








where 𝑐 ∈ 𝑅𝑛, 𝑏 ∈ 𝑅𝑚, 𝐴 ∈ 𝑅𝑚×𝑛 and 𝐵 = {0,1} 
  
   
 
SEM with IP for identifying DAG is then transformed into a score-based optimization problem 
for parameter and structure estimation (Jaakkola et al. 2002). We can define a DAG as 𝐺 =
(𝑉, 𝐸) where 𝑉 represents the nodes and 𝐸 represents edges. The set of causal variables of 𝒗 ∈
𝑉 defined as 𝐶𝑣, and the DAG can be denoted by the causal variables sets 𝐶 = {𝐶1, 𝐶2, … , 𝐶𝑝}. 
To construct a DAG 𝐷 is to select the optimal score of the summation of score functions 
(objective function): 𝑆(𝐷) =∑ 𝑆(𝑣, 𝐶𝑣)𝑣∈𝑉 . Then the score-based optimization problem is to 
search for a DAG that minimizes the global score 𝑆(𝐷)  over all possible DAGs, i.e. 
min
𝐷
∑ 𝑆(𝑣, 𝐶𝑣)𝑣∈𝑉,𝐶𝑣∈𝐷 , where global score is the summation of the score of each node, subject 
to the integer 0-1 constraint  (Xiong 2018):  
 










∀𝐶 ⊆ V: ∑ ∑ 𝑥(𝑊𝑗𝑣 → 𝑣)
𝑤𝑗𝑣
|𝑤𝑗𝑣∩𝐶|<𝑘,𝑗𝑣=1,…,𝑗𝑣𝑣∈𝐶
≥ 𝑘, ∀𝑘, 1 ≤ 𝑘 ≤ |𝐶| 




𝑣  represents a specific node 𝑣 , and  𝑊𝑗𝑣  refers to one of the possible parent set of 𝑣 . 
𝐶(𝑣, 𝑊𝑗𝑣) denotes the linear score function for the pair of node 𝑣  and its parent set 𝑊𝑗𝑣 .  
𝑥(𝑊𝑗𝑣 → 𝑣) = 1 if and only if  𝑊𝑗𝑣  is the parent set for the node 𝑣. 
 
Learning a DAG is then to identify the DAG with optimal score by searching all possible 
DAGs that are represented by the sets of parent variables. For each candidate DAG, it has a 
score measuring how well DAG fits the data. The task is to search for a DAG that optimizes 
the score via integer programming by searching all possible DAGs represented by the sets of 
parent variables. Take Figure 3 as an example, it showed all possible directed acyclic graph 
with three nodes. The task is to search for the best one with the optimal score via SEM with 
IP. 
 








With SEM plus integer programming to identify the optimal DAG, a causal analysis 
framework was created to discover the causal structures among multiple different variables 





2.2.2 Simulation Settings for Structural Equation Model 
 
The simulations were based on DNA methylation data. Two settings were set up. First, a 10-
nodes scenario was set up, with 6 nodes (endogenous variables) and 4 outside nodes 
(exogenous variables). 4 CpG sites (exogenous variables 𝑋) were randomly selected from 
DNA methylation in Alzheimer’s disease neuroimaging initiative (ADNI) datasets. The 
endogenous variables 𝑌 nodes were generated by:  
𝑌=𝐴𝑋+𝑒,    
where A~𝑈𝑛𝑖𝑓(1, 2),  𝑒~𝑁(0, 0.01) 
 
Then resampling was used to generate the simulated data of the sample size of 100, 300, 500 
and 1000, respectively. Second, the 20-nodes scenario was set up with 16 nodes 
(endogenous variables) and 4 outside nodes (exogenous variables).  The procedure was 
similar to the 10-nodes scenario, except that 16 endogenous variables were created. To 
compare the performance for SEM with and without integer programming, simulations for 
both methods were conducted under the two data scenarios. 
 
The DAGs with 10 nodes and 20 nodes were randomly generated as the ground truth. Both 
DAGs and the network data mentioned above were randomly generated for 1,000 times. 
Then we implemented SEM model for causal discoveries for the simulated data, and 
compared them with ground truth to evaluate performances. The two metrics for 
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comparisons were type 1 error and power of detection (PD). 𝑁𝑡 was defined to be the total 
number of edges existed among 1,000 networks in the randomly generated DAGs, 𝑁𝑜 be the 
total number of edges that did not appear in these 1,000 networks, 𝑁𝑇𝑟𝑢𝑒 be the total number 
of true edges discovered by the SEM algorithm for the simulated data, and 𝑁𝐹𝑎𝑙𝑠𝑒 be the 
false edges detected among 𝑁𝑜. Then the type 1 error rate was defined as  
𝑁𝐹𝑎𝑙𝑠𝑒
𝑁𝑜
 and power 
PD was defined as  
𝑁𝑇𝑟𝑢𝑒
𝑁𝑡
. These metrics were compared between SEM with and without 
integer programming, respectively. 
 
 
2.3 Methods for Aim 3 
 
Aim 3: To apply the ANM and SEM with IP to Alzheimer’s disease data and heart failure 
data, with the goal of uncovering the causal mechanism in terms of genetic and phenotypic 
information for the two diseases, respectively.  
 
2.3.1 Alzheimer’s Disease Data 
 
Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a multi-study that aims to improve 
clinical trials for the prevention and treatment of Alzheimer’s disease, which contains clinical, 
imaging, genetic, epigenetic, biomarkers information. Recently, there has been much research 
studying how epigenetic might affect the AD pathology, especially with DNA methylation. 
DNA methylation is a heritable epigenetic marker including the covalent transfer of a methyl 
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group that is added to DNA molecule (Jin et al. 2011). There have been studies indicating that 
DNA methylation is associated with AD pathology and demonstrate the potential to impact the 
AD phenotypes in these subjects (Yokoyama et al. 2017). However, past research for DNA 
methylation in aging and the development of Alzheimer‘s disease were focused on association 
analysis (GWAS), while lacking the causal framework to dissect the causal mechanism 
between DNA methylation and AD phenotypes. Our study is thus would like to utilize ANM 
and SEM as the causal framework to uncover how the DNA methylation affect the phenotypes 
and disease status of AD patients. Genome-wide causation analysis for DNA methylation on 
AD patients using ANM was first used to identify methylated genes that had pairwise causal 
effect on phenotypes of AD patients across three time points: baseline, 12 months, and 24 
months. Then, we can examine the progression of these causal relationships across time points.  
 
The dataset utilized is DNA methylation and phenotypes data in ADNI dataset, with 647 
subjects. There are 866,836 CpG sites for DNA methylation and 15 phenotypes after data-
preprocessing. Because of the relatively large number of CpG sites in DNA methylation and it 
is quite unstable and complex to put all the CpG sites into the SEM model and the 
computational cost could be quite expensive, bivariate ANM model as a genome-wide 
causation method was first used to filter and identify some candidate CpG sites (mapped to 
genes) and help us narrow down the target genes for later SEM analysis. And the p value cutoff 
for inferring causation is set to p value < 10−6 because of the computational cost of ANM and 
the number of permutation time was set to 106. The equation below is the expression of ANM, 
where 𝑌 is the effect, and 𝑋 is the cause. In our study, CpG sites were treated as cause and 
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phenotypes were treated as effect. Thus, the hypothesis being tested was whether certain CpG 
sites have a pairwise causal relationship with each phenotypes.  
𝑌 = 𝑓(𝑋) + 𝑒 
 
 
The pairwise causation analysis under ANM model was conducted between DNA methylation 
with 866,836 CpG sites and six memory and cognitive variables which are critical risk factors 
for AD: episodic memory, working memory, semantic memory, cognitive score, perceptive 
orientation, MMSE. 
 
After identifying causal genes by ANM, to better demonstrate the causal network structure 
among different phenotypic factors and the causal genes of AD, SEM with IP and DAG were 
also utilized to construct the network. There were 15 phenotypes analyzed in SEM model:   
a). Cognitive function traits:  cognitive score, perceptual orientation, perceptual speed, working 
memory, episodic memory, semantic memory and MMSE (mini mental state exam) 
b). Lipoprotein metabolism traits: cholesterol level (CHL), BMI, weight, diastolic blood 
pressure (DBP), systolic blood pressure (SBP), (SBP and DBP shared the same causal edges 
in our causal framework, so they were combined into one node “BP” for demonstration 
purpose in DAGs) 





In our analysis, phenotypic factors and disease status were considered as endogenous variables 
(𝑌) and the candidate causal genes were considered as exogenous variables (𝑋) in SEM model. 
 
 
2.3.2 Heart Failure Data 
 
Atherosclerosis Risk in Communities study (ARIC) is a prospective epidemiologic study 
conducted in four U.S. communities, with the goal of investigating the causes of 
atherosclerosis and its clinical outcomes, as well as variations in cardiovascular risk factors.  
 
This study utilized ANM and SEM with IP as tools to help uncover the causal pathway of 
genes – hexadecanedioate – blood pressure. The dataset for this study is ARIC, containing 
genotypes SNPs dosage data, phenotypic risk factors and hexadecanedioate metabolite. The 
dataset was divided into two sets: African Americans (1638 subjects), and European 
Americans (1428 subjects). There were 26,434,100 SNPs in African Americans and 
22,487,821 SNPs in European Americans to be analyzed. The following analysis was 
conducted for the two race groups separately. GWAS analysis was first conducted to filter 
SNPs that showed associations with hexadecanedioate (p value < 10−5 ). Then, pairwise 
causation analysis was conducted on the identified SNPs above using ANM to further discover 
SNPs that demonstrated causations with hexadecanedioate (because of the computational time 
limitation of permutation test in ANM, p value < 10−5 was set to infer causation). In our study 
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of ANM, SNPs were treated as cause and hexadecanedioate was treated as effect. Thus, the 
hypothesis being tested was whether certain SNPs have a pairwise causal relationship with 
hexadecanedioate levels. After filtering causal SNPs by pairwise ANM, minor allele frequency 
(MAF) cutoff of 5%, as well as linkage disequilibrium (LD) checking were also performed on 
the identified SNPs (mapped to genes).  
 
After obtaining several candidate causal genes that had causal effect on hexadecanedioate for 
the two race groups respectively from ANM, we incorporated them in to the SEM with IP 
model to further test for causal pathway. SEM as discussed in previous chapters, can 
accommodate more variables into the analysis and their interactions, which is different from 
the bivariate ANM. To better model genes – hexadecanedioate – blood pressure causal 
pathway, SEM with IP was utilized and more phenotypic factors were introduced into the 
model. The factors included: age, BMI, CHL, SBP, DBP, glucose level, prevalence of coronary 
heart disease (CHD), prevalence of hypertension (HTN), hypertension drug usage and 
prevalence of diabetes. In our analysis, hexadecanedioate and other phenotypic factors were 
considered as endogenous variables (𝑌)  and the candidate genes were considered as 
exogenous variables (𝑋) in SEM model. Since SBP and DBP shared common causal directions 
and relationships in our analysis, they were combined into one node (blood pressure) for 






2.4 Declaration on Human Subjects 
 
This dissertation research has a focus on statistical methods development on causal discovery 
on human genetic data when interventions in randomized controlled trials for causal inference 
is not feasible. The dataset utilized were Alzheimer’s Disease Neuroimaging Initiative (ADNI) 
and Atherosclerosis Risk in Communities study (ARIC). The information used in the dataset 
included DNA methylation and phenotypes data in ADNI dataset, and genotype SNPs data, 
phenotypes and metabolite data in ARIC dataset. All data were pre-existing and de-identified. 
The IRB approval for the use of dataset in my dissertation research was obtained by my 




3.1 Results for Aim 1 
 
The simulation results for ANM with permutation test were shown in Table 1 with the number 
of permutations being 500 times, and the significance level accessing being 0.05 level. 
 
Table 1 Power and Type1 error rate for ANM. 
 
  Power Type 1 error 
Nsample 500 1000 2000 500 1000 2000 
  




From Table 1, we could observe that the powers varied a lot among different sample sizes. 
With a sample size of 500, ANM could only achieve 62% of power. However, when the sample 
size increased to 2000, the power could reach 80%. This may suggest that ANM could 
potentially not work well in detecting causations when the sample sizes were below 500. Type 
1 error rates, on the other hand, were generally controlled at 0.05 significance level with slight 
inflation when the sample size reached 2000. However, it is also worth noting that the number 
of permutations was set to 500 times mainly because of the high computational cost of 
permutation test, especially with large sample sizes. Higher number of permutations and lower 
nominal significance level are worth exploring in future work to further validate the model 




3.2 Results for Aim 2 
 
The simulation results for SEM with IP in identifying the optimal DAG and causal structure 
were shown in Table 2 and Table 3.  
 










6 Nodes (endogenous variables) + 4 additional outside nodes (exogenous variables)  
 
 Power Type1 error 




0.6483 0.6844 0.7549 0.8117 0.1695 0.1477 0.1286 0.0908 





Table 3: Power and Type1 error rate for SEM with and without integer programming (20 
nodes) 
 
16 Nodes (endogenous variables) + 4 additional outside nodes (exogenous variables)   
 
 Power Type1 error 




0.6190 0.6553 0.7032 0.7603 0.1913 0.1710 0.1495 0.1143 
Only SEM 0.3225 0.3597 0.3985 0.4376 0.3108 0.2982 0.2691 0.2501 
 
 
Table 2 and Table 3 showed that SEM with integer programming performed significantly better 
than SEM only in terms of powers and type 1 error rates for both 10 nodes and 20 nodes 
scenarios. This result indicated that SEM plus the integer programming demonstrated better 
ability to detect causations among variables than SEM only. In addition, 10 nodes scenario 
showed better performance than 20 nodes scenario, indicating that the number of nodes may 
affect the ability for SEM to detect causations. Thus, it should be cautious when considering 
the number of nodes included in SEM models. Also, as sample sizes increased, the SEM 
method demonstrated greater ability to achieve better power and better controlled type 1 error 
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rate. Similar to ANM, the SEM with IP had expensive computational cost, especially when the 
number of parent nodes were high. Sometimes there maybe a trade-off between the 





3.3 Results for Aim 3 
3.3.1 Application of ANM and SEM with IP to Alzheimer’s Disease 
 
The tables (Table 4 to Table 9) below listed the genes that had pairwise causal relationships to 
the six memory and cognitive variables. 
 
Table 4: List of Candidate Genes with significant causations with Semantic Memory at 















Table 5: List of Candidate Genes with significant causations with Working Memory at 




Table 6:  List of Candidate Genes with significant causations with Episodic Memory at 




Table 7:  List of Candidate Genes with significant causations with Perceptive Orientation 
at three time points.  
 
 
























Table 8: List of Candidate Genes with significant causations with Cognitive Score at three 









We can see from Table 4 to Table 9 that that there were increasing number of genes (CpG sites) 
identified to be causal to the memory and cognitive traits above for AD patients as time 
progressed. And the causal genes discovered at early time point were quite different from those 
discovered at later point. We can also observe that at early points, the causal genes identified 
varied a lot for these memory and cognitive traits, however, we started to see some common 
causal genes for the different traits such as gene APP, PSEN1, MAPT and C9ORF72 at later 














memory, working memory and semantic memory at later time points. And these genes are 
confirmed in past literature that have critical causation relationships to the AD pathology.   
 
Since SEM plus integer programming cannot handle large number of nodes quite well and to 
better demonstrate the causal network, we only included the common causal genes that showed 
causations with several memory and cognitive traits at 12 months and 24 months by ANM: 
gene APP, PSEN1, MAPT and C9ORF72. At early time points (baseline), however, we 
included all the causal genes identified by ANM to the SEM model to further validate the 













































































































































































































































































































































In Figure 4 to Figure 6 above at three different time points, we observed the causal relationships 
among genes, phenotypes and AD disease status. From the phenotypic standpoint, it was 
evident that as disease progressed, more and more phenotypes, especially memory and 
cognitive traits were causally related to Alzheimer’s disease (the red dotted lines in the figures). 































































































the three time points, while semantic memory, MMSE and cognitive score demonstrated causal 
relations with AD at later time points. Genes were also identified under SEM and integer 
programing method to have causal relationships with various traits. Gene PSEN1 demonstrated 
causal relationships with semantic and working memory at 12 months and 24 months, 
suggesting that gene PSEN1 may be a genetic factor that influence the later stage of AD. And 
based on literature, gene PSEN1 are responsible for familial AD (Fenoglio et al. 2020). It is 
also worth noting that gene APP demonstrated causations with semantic, working and episodic 
memory at 24 months time point. And gene APP is also known as amyloid precursor protein 
(Lill and Bertram 2011), which is in the pathway of amyloid processing and plays a causal role 
in AD pathology (Lanoiselee et al. 2017). Gene CD33 showed causations with MMSE at both 
12 months and 24 months time points. Gene C9ORF72 was discovered to be causal to cognitive 
impairment and perceptual orientation at 24 months time points, and it has been discussed in 
literature that gene C9ORF72 repeat expansion is the most common cause of frontotemporal 
dementia (FTD) (Fenoglio et al. 2020). Lipoprotein metabolism traits such as CHL, BMI, 
weight and blood pressure did not seem to causally interact with the cognitive and memory 
traits for these subjects, nor the disease status. Based on the findings discussed above, the 
epigenetic effect of DNA methylation on the progression of Alzheimer’s disease was a 
dynamic process.  The genes that demonstrated causal pathway in AD were quite different 
between early and late time points. As time progressed, the genetic variants tended to have 






3.3.2 Application of ANM and SEM with IP to Heart Failure 
 
The results for identifying pairwise causal (SNPs) with hexadecanedioate by ANM were the 
following: for African American group, 164 SNPs were identified to be associated with 
hexadecanedioate, and 12 of these SNPs showed strong causal relationships to 
hexadecanedioate; for European American group, on the other hand, 154 SNPs showed 
association with hexadecanedioate while 17 of them demonstrated causations. Table 10 to 
Table 11 below listed the SNPs (mapped to genes) that showed both association and causation 
with hexadecanedioate for the two race groups.  
 
Table 10: P-values of SNPs that showed both significant associations and causations with 
hexadecanedioate for African Americans 
 
        P values 
RS Number Chr Position Gene Causation Association 
rs1439612183  chr8  7896243 DEFB4A <E-05 5.42E-11 
rs556278150 chr8   12285396   <E-05 2.69E-06 
rs4149056  chr12 21178615 SLCO1B1 <E-05 2.63E-06 
rs533352484 chr17  20011521 SPECC1 <E-05 7.79E-11 
rs188163008 chr17  20032631 SPECC1 <E-05 3.81E-12 
rs573822091  chr17   20102001 SPECC1 <E-05 3.50E-12 
rs550647571  chr17  20201747 SPECC1 <E-05 5.01E-10 
rs2136582  chr20  5711111   <E-05 1.36E-06 
rs2136581 chr20  5711116   <E-05 1.36E-06 
rs805741 chr20  5711493   <E-05 1.06E-06 
rs805725  chr20  5713480   <E-05 5.09E-06 





Table 11: P-values of SNPs that showed both significant associations and causations with 
hexadecanedioate for European Americans 
 
        P values 
RS Number Chr Position Gene Causation Association 
rs143987388  chr7   410515   <E-05 9.59E-06 
rs141778506 chr7    438554 LOC116435278 <E-05 2.19E-08 
rs149378705 chr7    442192   <E-05 2.08E-08 
rs570603161 chr7 702849 PRKAR1B <E-05 2.70E-06 
rs367595907 chr7    839818 SUN1 <E-05 5.54E-06 
rs141369986  chr12  1282768 ERC1 <E-05 4.25E-06 
rs4149056  chr12  21178615 SLCO1B1 <E-05 1.08E-09 
rs144705402 chr13    18692976   <E-05 7.52E-06 
rs775545390 chr16   1062396   <E-05 1.51E-10 
rs182744734 chr16   1152890 CACNA1H <E-05 6.59E-06 
rs867598991  chr16   1153217 CACNA1H <E-05 6.58E-06 
rs111330505  chr17   1636474 SCARF1 <E-05 8.90E-09 
rs77446883 chr17   1692215   <E-05 3.59E-08 
rs773417326  chr19   718853 PALM <E-05 9.21E-08 
rs1374594991 chr21   5131154 LOC102724159 <E-05 1.74E-08 
 
 
Minor allele frequency (MAF) cutoff of 5% were then applied for the SNPs identified above 









Table 12: P-values of SNPs that showed both significant associations and causations with 
hexadecanedioate with a 5% MAF cutoff for African Americans 
     P value  
RS Number Chr Pos Gene Causation Association MAF 
rs11685543 chr2 11466521   <E-05 2.89E-09 0.2 
rs556278150 chr8   12285396   <E-05 2.69E-06 0.071 
rs4149056  chr12 21178615 SLCO1B1 <E-05 2.63E-06 0.066 
rs2136582  chr20  5711111   <E-05 1.36E-06 0.298 
rs2136581 chr20  5711116   <E-05 1.36E-06 0.298 
rs805741 chr20  5711493   <E-05 1.06E-06 0.297 
rs805725  chr20  5713480   <E-05 5.09E-06 0.315 
 
 
Table 13: P-values of SNPs that showed both significant associations and causations with 
hexadecanedioate with a 5% MAF cutoff for European Americans 
     P value   
RS Number Chr Pos Gene Causation Association MAF 
rs141369986  chr12  1282768 ERC1 <E-05 4.25E-06 0.05 
rs4149056  chr12  21178615 SLCO1B1 <E-05 1.08E-09 0.16 
rs111330505  chr17   1636474 SCARF1 <E-05 8.90E-09 0.05 
 
 
For SNPs in Table 12 and Table 13, the linkage disequilibrium (LD) were also checked among 
them, and the results showed that the four SNPs on chromosome 20 in Table 12 for African 
American group were highly correlated and were in high LD (𝑅2 values close to 1). As a result, 
we could only retain one of these four SNPs in the following analysis. Table 14 and Table 15 
below were the SNPs included in the SEM model for further analysis (four for African 




Table 14: SNPs identified to have causations with hexadecanedioate for African 
Americans after checking LD 
 
RS Number Chr Pos Gene 
rs11685543 chr2 11466521  
rs556278150 chr8   12285396  
rs4149056  chr12 21178615 SLCO1B1 




   
Table 15: SNPs identified to have causations with hexadecanedioate for European 
Americans after checking LD 
 
RS Number Chr Pos Gene 
rs141369986  chr12  1282768 ERC1 
rs4149056  chr12  21178615 SLCO1B1 
rs111330505  chr17   1636474 SCARF1 
 
 
Based on the results above from ANM in Table 14 and Table 15, we obtained several candidate 
genes that have causal effect on hexadecanedioate for the two race groups respectively, to be 
further tested for causal pathway. It is worth noting that SNP rs4149056 (chr12, position 
21178615), mapped to gene SLCO1B1 (labeled in red in above tables), has been discussed in 
literature that demonstrated association with hexadecanedioate for the TwinsUK and KORA 
cohorts (Mennie et al. 2017). SEM with IP was next utilized to better model genes – 
hexadecanedioate – blood pressure causal pathway. To better demonstrate the analysis 
incorporating other phenotypic factors, directed acyclic graphs (DAGs) identified by SEM 




Figure 7 and Figure 8 demonstrated the causal network constructed incorporating candidate 
causal genes, phenotypic and the metabolite (hexa): 
 








Figure 8:  Causal Network for European American Group 
  
 
SEM with IP was conducted for both race groups, and Figure 7 and Figure 8 indicated that 
gene SLCO1B1 (rs4149056 on chromosome 12) had causal effect on both hexadecanedioate 
and blood pressure (SBP and DBP) for African American group. The SNP rs4149056 encodes 




and this protein is found primarily in the liver which regulates the uptake of numerous drugs 
and natural compounds (SNPedia, 2020). 
 
For European American group, on the other hand, gene SLCO1B1 (rs4149056 on chromosome 
12) and gene SCARF1 (rs111330505 on chromosome 17) were identified to have causal effect 
on both hexadecanedioate and blood pressure (SBP and DBP). SNP rs111330505 encodes the 
protein which is a scavenger receptor that is expressed in endothelial cells. It regulates the 
uptake of chemically modified low density lipoproteins, including acetylated low-density 
lipoprotein (Ac-LDL), and it may be involved in atherogenesis (NCBI, 2020). And for both 
race groups, hexadecanedioate was discovered to have causal relationships on blood pressure 
(SBP and DBP).  
 
Causal pathways for gene- hexadecanedioate-blood pressure were discovered by ANM and 
SEM with IP methods. ANM was first utilized as a feature selection tool to identify candidate 
genes that showed causal effect on hexadecanedioate. Then SEM with IP was implemented 
incorporating the identified candidate genes and other phenotypic factors to model a more 
complex causal network. The analysis was conducted for two race groups separately. Gene 
SLCO1B1 was identified to have causal effects on both hexadecanedioate and blood pressure 
for African American group, and gene SLCO1B1 and gene SCARF1 were observed in the same 
way for European American group. Hexadecanedioate was discovered to have causal 




There has been several GWAS studies assessing the pathway of genes, hexadecanedioate and 
blood pressure under association framework. However, there is limited research uncovering 
causal relationships for the three factors mentioned above. Using ANM and SEM with IP, gene 
SLCO1B1 (on chromosome 12), which was previously identified to be associated with 
hexadecanedioate and blood pressure (Menni et al. 2015, 2017; Yu et al. 2016), was discovered 
to have causal effect on both hexadecanedioate and blood pressure for both African and 
European Americans. And the causal effect of hexadecanedioate on blood pressure was 
discovered by our network causal discovery framework. In addition, novel discoveries of gene 
SCARF1 (on chromosome 17) for European American group was identified to have causal 
effects on both hexadecanedioate and blood pressure. Our findings provided more insights for 
unraveling the causal pathway of gene- hexadecanedioate-blood pressure. We discovered a 
few genetic loci that could potentially be causal to hexadecanedioate and further affect blood 
pressure, in addition to the current GWAS association analysis framework. And our results 
could provide more information that worth further investigation in future research.  
 
 
4. DISCUSSIONS AND CONCLUSIONS 
 
4.1 Discussions and Conclusions 
 
The goal of this dissertation research was to propose methods for causal discovery in 
genetic/epigenetic studies when randomized controlled experiment is infeasible. In past 
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literature, the major framework to uncover genetic variants that play critical roles in disease 
pathology such as Alzheimer’s disease and heart failure is association analysis. GWAS study 
has been widely employed to study complex diseases. However, the signals uncovered by 
association analysis can only discover a small proportion of variants and may omit critical 
signals. Thus, the transition from association framework to causal framework could facilitate 
the research in bioinformatics in understanding disease mechanisms. Mainly for ethical and 
technical reasons, traditional gold standard for causal inference which is interventions in 
randomized controlled trials is not feasible for human genetics data.  As a result, we proposed 
two methods in this dissertation to handle causal discovery in genetic analysis of AD and HF. 
 
The first method proposed is a bivariate causal discovery method called ANM for 
continuous variables. ANM could discover the causal relationships between two observed 
variables, where effect is modeled as a non-linear function of cause, plus a random error. 
However, with only ANM, it is impossible to get the closed analytical forms for the 
asymptotic null distribution of the HSIC, which makes it difficult to calculate the p-values 
of the independence tests between the cause and the residual term. To overcome the 
limitations, we proposed adding a permutation test to calculate the p-values of the causal 
test statistics. The simulation results indicated that ANM performed well in terms of 
controlling type 1 error rates to reasonable level, and the power could reach 80% as sample 
size increase to 2000. However, the number of permutation test was set to 500 in our 
simulation setting because of the computational cost, higher number of permutations may 
worth exploring to better validate the model performance in the future. It is also worth 
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exploring the lower nominal significance level (such as 0.01) to better control type 1 error 
rate for the model. 
  
In addition to bivariate causal discovery, we also proposed network causal discovery method 
to accommodate more variables into the analyses and accounted for the correlations among 
different types of variants. SEM is a causal method used to describe the causal relations among 
endogenous and exogenous variables. However, with SEM only, it could potentially generate 
a bidirectional relationship between variables, instead of unidirectional, thus generating cyclic 
graphs, instead of an acyclic graph. To overcome the limitations, we proposed adding an extra 
integer programming step to SEM model, transforming DAG learning to an optimization 
problem and searching for the best DAG and causal structure for the variables. We combined 
DAG and SEM plus integer programming as the network causal discovery method to model 
complex causal structures. The simulation for 10 nodes and 20 nodes cases indicated this 
combined method had better ability to detect causations among variables than SEM only. 
However, SEM with IP also demonstrated expensive computational cost, especially when the 
numbers of parent node were set to higher numbers. As a result, there is sometimes a trade-off 
between computational time and better model performance.  
 
In summary, we could first utilize ANM as a feature selection tool to help us identify and 
screen some candidate causal genetic loci from the large number of genetic variants. Then we 
could use SEM plus integer programming method to model the interactions among candidate 
causal variants and other factors (i.e. phenotypes) to describe more complex causal networks. 
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To see if this ANM+SEM and integer programming causal analysis framework works well in 
real world data, we applied this framework to AD (ADNI) and HF (ARIC) data, respectively.  
 
For Alzheimer’s disease, we discovered several DNA methylations (CpG sites mapped to 
genes) that played causal role in disease pathology. For example, gene APP and PSEN1 were 
identified by our framework to be causal to several memory and cognitive traits for AD 
subjects, and both of these genes were confirmed in literature. In addition to the causal genes 
we discovered that could be confirmed by literature, novel causal genes especially at early time 
points of AD were also uncovered, which provided clues for future clinical and biological 
researchers to validate the results. 
  
For heart failure, we uncovered the causal pathway of genes – hexadecanedioate – blood 
pressure. Previous research showed several SNPs (mapped to genes) were associated with 
hexadecanedioate metabolite, and hexadecanedioate were associated with BP. In our analysis, 
we discovered that gene SLCO1B1 (on chromosome 12), which was previously identified to 
be associated with hexadecanedioate and blood pressure (Menni et al. 2015, 2017; Yu et al. 
2016), showed causal effect on both hexadecanedioate and blood pressure for both African and 
European Americans. We also found out that hexadecanedioate was causal to blood pressure 





4.2 Future Works 
 
First, for Aim 3 heart failure ARIC application study, additional analysis may worth exploring. 
Since a 5% cutoff of MAF on SNPs were applied, we only focused on common SNPs for both 
race groups, while lacking the ability to accommodate rare variants into the analysis. In 
addition, the power to detect statistically significant rare variant associations and causations 
decrease as the MAFs decrease, so there is a need to find methods to accommodate such 
situation. One possible solution could be grouping rare variants together at the level of gene. 
We could explore functional principal component analysis (FPCA) (Xiong 2018) to summarize 
genetic variations within genes. FPCA is widely used for GWAS with next-generation 
sequencing data (Luo et al. 2011) and hence can also be applied to causation studies between 
two variables. Functional principal component (FPC) is an extension of principal component 
and can be used as summary statistics. FPCs can utilize genetic information of the individual 
variants as well as correlation information (LD) among variants. The FPCs summarizes genetic 
variation across the genomic region as a function of its genomic location, and employs intrinsic 
functional dependence structure of the data and all available genetic information of the variants 
in the genomic region (Wang et al. 2016). Specifically, we could summarize individual SNPs 
into continuous functional principal component scores and collectively use rare variant 
information. We could then use these continuous FPC scores as the variables for both bivariate 




Second, for bivariate ANM, we only focused on handling two continuous variables while not 
studying the causal relationships between two discrete variables, or one continuous and one 
discrete variable. Since genetic data usually takes on various data types, it would be helpful to 
explore different data types under ANM method. In two continuous ANM, the independence 
test between cause and the residual term is HSIC. However, for two discrete variables case, 
other test method such as chi-square test may be employed and worth exploring. 
 
Third, for SEM with integer programming, we only focused on small number of nodes scenario 
mainly because of the expensive computational cost of integer programming. However, the 
biological system is rather complex and sometimes the interactions can be quite complicated 
among large number of variables. Future work could be to increase the number of nodes and 
vary the ratios of endogenous variables and exogenous variables to further assess the stability 
of SEM with integer programming. In addition, the SEM with IP we proposed took linear 
relationships among variables, however, it is also worth exploring the non-linear form of the 
relationships in the future. For example, nonlinear SEMs including complex ANMs can also 
be used to discover causal networks. Also, the SEM with IP we proposed is a cross-sectional 
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